Sedlak v. Saul

CourtDistrict Court, D. Nebraska
DecidedAugust 8, 2019
Docket8:18-cv-00515
StatusUnknown

This text of Sedlak v. Saul (Sedlak v. Saul) is published on Counsel Stack Legal Research, covering District Court, D. Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sedlak v. Saul, (D. Neb. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEBRASKA WILLIAM J. SEDLAK, ) ) Plaintiff, ) 8:18CV515 ) v. ) ) MEMORANDUM ANDREW SAUL, Commissioner of ) AND ORDER Social Security, ) ) Defendant. ) ) Plaintiff William Sedlak brings this action under Titles II and XVI of the Social Security Act, which provide for judicial review of “final decisions” of the Commissioner of the Social Security Administration. 42 U.S.C. § 405(g) (Westlaw 2019).1 I. NATURE OF ACTION & PRIOR PROCEEDINGS A. Procedural Background Sedlak filed an application for disability benefits on January 27, 2016, under Titles II and XVI. The claims were denied initially and on reconsideration. On March 21, 2018, following a hearing, an administrative law judge (“ALJ”) found that Sedlak was not disabled as defined in the Social Security Act. (Filing No. 10-2.) On August 27, 2018, the Appeals Council of the Social Security Administration denied Sedlak’s request for review. (Filing No. 10-2 at CM/ECF pp. 1-5.) Thus, the decision of the ALJ stands as the final decision of the Commissioner. Sims v. Apfel, 530 U.S. 103, 1Plaintiff originally named Nancy A. Berryhill, Acting Commissioner of Social Security, as the Defendant in this action. Andrew Saul became the Commissioner of Social Security on June 17, 2019, and has been automatically substituted as a party pursuant to Fed. R. Civ. P. 25(d). 107 (2000) (“if . . . the Council denies the request for review, the ALJ’s opinion becomes the final decision”). B. Medical & Opinion Evidence; Sedlak’s Testimony

1. Medical Evidence

The material medical evidence related to Sedlak’s impairments is undisputed and is described by the ALJ as follows2: The medical evidence confirms that the claimant has been diagnosed with myasthenia gravis3 since before the alleged onset date. In January 2016, an electromyogram was performed, which confirmed median and sensory neuropathy of the left upper extremity. Specifically, the abnormal study showed electrophysiologic evidence of: proximal subacute and active motor median neuropathy; postsynaptic neuro[muscular] junction disorder; and sensory neuropathy. The medical evidence also confirms the claimant’s left shoulder tendinosis.4 Prior to the amended alleged onset date, in 2015, the claimant presented to the emergency department various times with complaints of left shoulder pain. The claimant was referred to an orthopedist, Matthew J. Teusink, MD, and in August 2015 and September 2015, Dr. Teusink observed some decreased strength with supraspinatus, but full 5/5 strength with external rotation and no pain 2The ALJ’s citations to exhibit numbers have been deleted to conserve space. 3 According to the Johns Hopkins Medicine website, “Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth, throat and limbs.” https://www.hopkinsmedicine.org/health/ conditions-and-diseases/myasthenia-gravis. 4The ALJ uses “tendinosis” and “tendonosis” interchangeably. 2 with passive range of motion of the left shoulder. An MRI of the left shoulder performed August 20, 2015 indicated tendonosis of the left shoulder. The imaging revealed advanced tendinosis of the infraspinatus; advanced atrophy supraspinatus/infraspinatus; moderate to advanced tendinosis subscapularis with small distal intrasubstance tear; mild atrophy subscapularis; mild tendinosis long head biceps tendon; complex tear to anterior inferior glenoid labrum; and findings suggestive of adhesive capsulitis. The objective evidence indicates that when considered in combination with his myasthenia gravis and neuropathy, his left shoulder tendinosis impairment is severe. During the period under review, the claimant treated for these conditions with his primary care provider, Dr. Hoeft, who he saw approximately every two to four months until June 2017. In September 2017, the claimant started treating with Tyrus S. Soares, MD, a pain specialist, who he saw three times through December 2017. The claimant also treated with a neurologist, Ezequiel A. Piccione, MD, for management of myasthenia gravis, who he saw four times from the alleged onset date through December 2017. The claimant was treated with prescribed medication, including prednisone. . . . [O]n December 8, 2017, Dr. Piccione documented some decreased strength of the left upper extremity rated at 4+/5 and 5-/5, along with 4+/5 strength of bilateral ankle dorsi flexors. Dr. Piccione further observed normal muscle bulk and tone with no atrophy, along with normal coordination. . . . The medical evidence additionally confirms that the claimant has a history of a right ankle fracturing requiring post an open reduction internal fixation surgery, which occurred prior to the alleged onset date. Dr. Soares assessed him with chronic ankle pain and osteoarthritis of the bilateral ankles. . . . His treating examiners observed some edema and tenderness at times, along with decreased 4+/5 strength of the ankle dorsi flexors. In January 2016 and July 2016, Dr. Piccione did not document any abnormalities with regard to the claimant’s gait. In May 2017 and December 2017, Dr. Piccione noted that the claimant was unable to walk 3 on tip-toes or heels bilaterally, but he was able to walk steps in tandem, to get out of a chair without pushing off, and was able to squat, and Romberg sign was absent. The medical evidence does not indicate that the claimant has been prescribed an assistive walking device, not has he been observed to be using one. . . . The medical evidence shows that the claimant was prescribed opiate medication for this condition during the period under review. He was initially prescribed the opiates by his primary care provider, Dr. Hoeft, until September 2017, when Dr. Soares start[ed] prescribing it to him. In October 2017, the claimant reported to Dr. Soares that the opiate medication was “effective[”] and that his pain symptoms were “stable.” He made similar reports to Dr. Soares in December 2017 and additionally reported that his ankle pain was “generally tolerable and he is functional and mobile.” . . . . . . . . . . [E]ven though the claimant was prescribed opiates, urine drug screen tests performed in March 2017 and June 2017 revealed negative results for opiates. . . . The evidence of record confirms that the claimant has ptosis5 secondary to his myasthenia gravis. Ptosis of the left eye was obvious at the hearing, and it has been documented by various medical providers. . . . (Filing No. 10-2 at CM/ECF pp. 30-32.) 2. Opinion Evidence The ALJ gave “some weight” to the opinions of Sedlak’s treating physicians, 5According to the American Academy of Ophthalmology, “Ptosis is when the upper eyelid droops over the eye. The eyelid may droop just a little, or so much that it covers the pupil . . . . Ptosis can limit or even completely block normal vision.” https://www.aao.org/eye-health/diseases/what-is-ptosis. 4 Dr. Piccione, a neurologist, and Dr. Hoeft. Dr. Piccione’s opinions are undisputed and described by the ALJ as follows6: . . . In a letter dated August 1, 2016, Dr. Piccione stated that the claimant’s symptoms vary day to day, making it difficult to maintain consistent employment. In a letter dated June 26, 2017, Dr. Piccione stated that the claimant’s symptoms had become worse, he was having more diffuse muscle weakness, and he was having worsening ptosis on the right. He stated this made it difficult for the claimant to hold employment. In May 2017, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vossen v. Astrue
612 F.3d 1011 (Eighth Circuit, 2010)
Hurd v. Astrue
621 F.3d 734 (Eighth Circuit, 2010)
Partee v. Astrue
638 F.3d 860 (Eighth Circuit, 2011)
Bertha Eichelberger v. Jo Anne B. Barnhart
390 F.3d 584 (Eighth Circuit, 2004)
Angela Myers v. Carolyn W. Colvin
721 F.3d 521 (Eighth Circuit, 2013)
Sims v. Apfel
530 U.S. 103 (Supreme Court, 2000)
House v. Astrue
500 F.3d 741 (Eighth Circuit, 2007)
Kirby v. Astrue
500 F.3d 705 (Eighth Circuit, 2007)
Wildman v. Astrue
596 F.3d 959 (Eighth Circuit, 2010)
Kandi Cline v. Carolyn W. Colvin
771 F.3d 1098 (Eighth Circuit, 2014)
Karl Wright v. Carolyn W. Colvin
789 F.3d 847 (Eighth Circuit, 2015)
Martha Aulston v. Michael Astrue
277 F. App'x 663 (Eighth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Sedlak v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sedlak-v-saul-ned-2019.